- CIIX
CEO Warren Wang and CBD Biotech executives attended 2019 China Industrial
Cannabis CBD Industry International Conference
- At
well over one billion people, China’s cannabis industry market potential
is four times the size of America’s
- CEO
responds to stock’s fluctuating volatility, urges shareholders to continue
to invest
ChineseInvestors.com
Inc. (OTCQB: CIIX) is a leading purveyor of financial information and
education for Chinese-speaking investors in the United States and China
providing real-time market commentary, analysis, and educational-related
services in Chinese character language sets. The products and services offered
help investors make informed decisions and meet individualized financial goals.
After creating inroads into the lucrative cannabis sector in the United States
through its subsidiary CBD Biotech Inc., CIIX is leveraging its own financial
expertise to establish itself as a leader in China’s emerging CBD industry.
On November 23-24, CBD Biotech executives attended the 2019
China Industrial Cannabis CBD Industry International Conference in Haerbing,
China. Warren Wang, CEO of CIIX, joined Donald Baillargeon on MoneyTV to
share highlights from the conference and recent company news.
Wang described the conference’s focus on the hemp/CBD
industry in China, which cemented his belief that the industry has a bright
future. China’s cannabis industry is in the early stage of development and has
a large potential for growth. Institutional investors, analysts, and fund
managers who are interested in the opportunities both in China and offshore
were in attendance. Legalizations is slow in China, but the laws are changing, and
investors are looking for potential opportunities. With approximately 1.4
billion people, China has four times the market potential of America. In
a Wall Street Journal video, titled ‘Why China is Betting Big
on CBD’ (http://ibn.fm/UwOFI),
the consensus among Chinese entrepreneurs is that while the U.S. is a currently
a major player, the future of the cannabis industry belongs to China.
CBD Biotech executives were on hand at November’s conference
to feature new products and provide information and education on current
products. The company is one of the first to enter this market and has laid the
foundation for success as the hemp/CBD industry continues to grow in
China (http://ibn.fm/2RjQj).
In the MoneyTV interview with Baillargeon,
Wang also responded to CIIX stock’s fluctuating volatility, speaking to the
company’s strong management team and focused achievement of long-term
objectives. He reminded shareholders of Amazon’s early days where the value of
stocks would fluctuate dramatically. Since CIIX is still a young company and
has a promising future, Wang commented that “short term stock volatility is not
going to effect the long-term picture.” For now, he encourages those who
believe in CIIX to invest disposable money.
The strength of CIIX lies in its management team, long-term
goals and strategy, and placement in a potentially explosive market.
For more information, visit the company’s website at www.ChineseInvestors.com
NOTE TO INVESTORS: The latest news and updates
relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
